Venoarterial Extracorporeal Membrane Oxygenation in Sickle Cell Disease for Urgent Cardiac Surgery

Ann Thorac Surg. 2020 Mar;109(3):e161-e162. doi: 10.1016/j.athoracsur.2019.05.093. Epub 2019 Jul 27.

Abstract

Sickle cell disease (SCD) is among the most common genetic diseases, with a recent increase in life expectancy. Patients may therefore need similar surgical procedures as does the general population, including cardiac surgery. Cardiopulmonary bypass is a homeostasis challenge for SCD patients, with high risk of vasoocclusive crisis. In the most severe cases of cardiogenic shock, venoarterial extracorporeal membrane oxygenation (VA-ECMO) may be required, with prolonged exposure to extreme nonphysiological conditions. We report a case of postcardiotomy shock in an SCD patient successfully managed with VA-ECMO. This highlights that SCD should not be a counterindication to VA-ECMO, pending multidisciplinary management.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Sickle Cell / complications
  • Cardiac Surgical Procedures
  • Emergency Treatment*
  • Extracorporeal Membrane Oxygenation / methods*
  • Female
  • Femoral Artery
  • Femoral Vein
  • Humans
  • Jugular Veins
  • Postoperative Complications / therapy*
  • Shock / therapy*